JOHN L. HIGGINS - 01 May 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
01 May 2025
Net transactions value
+$262,080
Form type
4
Filing time
05 May 2025, 16:18:21 UTC
Previous filing
21 Mar 2025
Next filing
13 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HIGGINS JOHN L Director 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed 05 May 2025 0001208906

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $262,080 +12,000 +25% $21.84 60,196 01 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -12,000 -70% $0.000000 5,040 01 May 2025 Common Stock 12,000 $21.84 Direct
holding TECH Stock Options (Right to Buy) 15,940 01 May 2025 Common Stock 15,940 $25.30 Direct
holding TECH Stock Options (Right to Buy) 12,500 01 May 2025 Common Stock 12,500 $31.26 Direct
holding TECH Stock Options (Right to Buy) 7,592 01 May 2025 Common Stock 7,592 $44.96 Direct
holding TECH Stock Options (Right to Buy) 8,044 01 May 2025 Common Stock 8,044 $50.41 Direct
holding TECH Stock Options (Right to Buy) 6,028 01 May 2025 Common Stock 6,028 $63.92 Direct
holding TECH Stock Options (Right to Buy) 2,532 01 May 2025 Common Stock 2,532 $128.81 Direct
holding TECH Stock Options (Right to Buy) 3,460 01 May 2025 Common Stock 3,460 $73.94 Direct
holding TECH Stock Options (Right to Buy) 3,937 01 May 2025 Common Stock 3,937 $61.51 Direct
holding TECH Stock Options (Right to Buy) 3,511 01 May 2025 Common Stock 3,511 $68.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.